Cargando…
The Use of Tocilizumab in Patients with COVID-19: A Systematic Review, Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Studies
Background: Among the several therapeutic options assessed for the treatment of coronavirus disease 2019 (COVID-19), tocilizumab (TCZ), an antagonist of the interleukine-6 receptor, has emerged as a promising therapeutic choice, especially for the severe form of the disease. Proper synthesis of the...
Autores principales: | Maraolo, Alberto Enrico, Crispo, Anna, Piezzo, Michela, Di Gennaro, Piergiacomo, Vitale, Maria Grazia, Mallardo, Domenico, Ametrano, Luigi, Celentano, Egidio, Cuomo, Arturo, Ascierto, Paolo A., Cascella, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584705/ https://www.ncbi.nlm.nih.gov/pubmed/34768455 http://dx.doi.org/10.3390/jcm10214935 |
Ejemplares similares
-
Rapid and Impressive Response to a Combined Treatment with Single-Dose Tocilizumab and NIV in a Patient with COVID-19 Pneumonia/ARDS
por: Cascella, Marco, et al.
Publicado: (2020) -
Utilizing an artificial intelligence framework (conditional generative adversarial network) to enhance telemedicine strategies for cancer pain management
por: Cascella, Marco, et al.
Publicado: (2023) -
Satisfaction with Telemedicine for Cancer Pain Management: A Model of Care and Cross-Sectional Patient Satisfaction Study
por: Cascella, Marco, et al.
Publicado: (2022) -
Spontaneous peritonitis in critically ill cirrhotic patients: a diagnostic algorithm for clinicians and future perspectives
por: Fiore, Marco, et al.
Publicado: (2017) -
Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis
por: Isgrò, Maria Antonietta, et al.
Publicado: (2021)